You are here

Article info

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1125 In vitro characterization of cellular responses elicited by endosomal TLR agonists encapsulated in Qβ virus-like particles

Authors

  • MM Hasibuzzaman The University of Iowa, Iowa City, IA, USA Department of Pathology, University of Iowa, Iowa City, IA, USA PubMed articlesGoogle scholar articles
  • Briana Ibarra San Jacinto College, Houston, TX, USA PubMed articlesGoogle scholar articles
  • Ishrat Khan The University of Iowa, Iowa City, IA, USA Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA, USA PubMed articlesGoogle scholar articles
  • Caitlin D Lemke-Miltner Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA Department of Oral Pathology, Radiology and Medicine, University of Iowa, Iowa City, IA, USA PubMed articlesGoogle scholar articles
  • George J Weiner Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA Department of Oral Pathology, Radiology and Medicine, University of Iowa, Iowa City, IA, USA PubMed articlesGoogle scholar articles
  • Andrean L Simons Department of Pathology, University of Iowa, Iowa City, IA, USA Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA, USA Department of Oral Pathology, Radiology and Medicine, University of Iowa, Iowa City, IA, USA PubMed articlesGoogle scholar articles

Citation

Hasibuzzaman M, Ibarra B, Khan I, et al
1125 In vitro characterization of cellular responses elicited by endosomal TLR agonists encapsulated in Qβ virus-like particles
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.1125
Online issue publication 
November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.